Arca
Skip to content
Tools
Tools

EVA5 Insufflator

Insufflator, Automatic Carbon-Dioxide For Endoscope. 510(k) K230474, from Palliare , Ltd. (Galway, IE). Product code FCX, class 2.

As of Nov 18, 2026, K230474 is an FDA 510(k) held by Palliare , Ltd., substantially equivalent on Mar 24, 2023 after 30 days, with no recalls tied to it in FDA's recall database.

  • Review time: 30 days
  • Recalls: 0
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The EVA5 Insufflator is intended for use in diagnostic and/or therapeutic endoscopic procedures to distend the gastrointestinal tract by filling it with gas.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Other FCX clearances

The newest 510(k)s for the same product code; their median review was 217 days; see every FCX device

Record

Type
Special
Received
Feb 22, 2023
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1500

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.